发明名称 |
Compositions and methods for inhibiting expression of the HAMP gene |
摘要 |
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the HAMP gene (HAMP gene), comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the HAMP gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by HAMP gene expression and the expression of the HAMP gene using the pharmaceutical composition. |
申请公布号 |
US8791250(B2) |
申请公布日期 |
2014.07.29 |
申请号 |
US201313900854 |
申请日期 |
2013.05.23 |
申请人 |
Alnylam Pharmaceuticals, Inc. |
发明人 |
Nakayama Tomoko;Geick Anke;Tan Pamela;Lin Herbert Y. |
分类号 |
C12N15/11;A61K48/00;C07H21/02;C07H21/04 |
主分类号 |
C12N15/11 |
代理机构 |
Fenwick & West LLP |
代理人 |
Fenwick & West LLP |
主权项 |
1. A double-stranded ribonucleic acid (dsRNA), wherein the dsRNA comprises an antisense strand and a sense strand, wherein each strand is less than 30 nucleotides in length, and wherein the target sequence of the dsRNA comprises the first nineteen nucleotides of SEQ ID NO:29 (GAACAUAGGUCUUGGAAUA). |
地址 |
Cambridge MA US |